James R. Rusche

4.6k total citations
55 papers, 3.6k citations indexed

About

James R. Rusche is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Virology. According to data from OpenAlex, James R. Rusche has authored 55 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 20 papers in Cellular and Molecular Neuroscience and 11 papers in Virology. Recurrent topics in James R. Rusche's work include Histone Deacetylase Inhibitors Research (15 papers), Genetic Neurodegenerative Diseases (11 papers) and HIV Research and Treatment (11 papers). James R. Rusche is often cited by papers focused on Histone Deacetylase Inhibitors Research (15 papers), Genetic Neurodegenerative Diseases (11 papers) and HIV Research and Treatment (11 papers). James R. Rusche collaborates with scholars based in United States, Austria and Belgium. James R. Rusche's co-authors include Thomas J. Daly, Vincent Jacques, Joel Gottesfeld, Kathleen Sue Cook, Marcelo A. Wood, Joachim Hauber, Theodore E. Maione, George A. Rogge, Susan C. McQuown and Gary S. Gray and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

James R. Rusche

55 papers receiving 3.6k citations

Peers

Countries citing papers authored by James R. Rusche

Since Specialization

Citations

This map shows the geographic impact of James R. Rusche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Rusche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Rusche more than expected).

Fields of papers citing papers by James R. Rusche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. Rusche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Rusche. The network helps show where James R. Rusche may publish in the future.

Co-authorship network of co-authors of James R. Rusche

This figure shows the co-authorship network connecting the top 25 collaborators of James R. Rusche. A scholar is included among the top collaborators of James R. Rusche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Rusche. James R. Rusche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington’s Disease Mice 2016 ·PLoS ONE ·Haiqun Jia, Ying Wang, Charles D. Morris, Vincent Jacques, Joel Gottesfeld, James R. Rusche, Elizabeth A. Thomas	76
2	DcpS is a transcript-specific modulator of RNA in mammalian cells 2015 ·RNA ·Mi Zhou, Sophie Bail, Heather L. Plasterer, James R. Rusche, Megerditch Kiledjian	16
3	Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreichâ€™s Ataxia 2015 ·Frontiers in Neurology ·Elisabetta Soragni, C. James Chou, James R. Rusche, Joel Gottesfeld	25
4	Development of Frataxin Gene Expression Measures for the Evaluation of Experimental Treatments in Friedreich’s Ataxia 2013 ·PLoS ONE ·Heather L. Plasterer, Éric Deutsch, Matthew A. Belmonte, Elizabeth S. Egan, David R. Lynch, James R. Rusche	31
5	Histone deacetylases 1 and 2 maintain S-phase chromatin and DNA replication fork progression 2013 ·Epigenetics & Chromatin ·Srividya Bhaskara, Vincent Jacques, James R. Rusche, Eric N. Olson, Bradley R. Cairns, Mahesh B. Chandrasekharan	57
6	The DcpS inhibitor RG3039 improves motor function in SMA mice 2013 ·Human Molecular Genetics ·(unknown), (unknown), Heather L. Plasterer, Wenyan Miao, Zhihua Feng, (unknown), Agnieszka A. Rucki, (unknown), Bing Xia, (unknown), Vincent Jacques, Darrick K. Li, Livio Pellizzoni, James R. Rusche, Chien-Ping Ko, Charlotte J. Sumner	50
7	Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease 2012 ·Neurobiology of Disease ·Haiqun Jia, Judit Pallos, Vincent Jacques, Alice Lau, Bin Tang, (unknown), Adeela Syed, Judith Purcell, Yi Chen, (unknown), Gavin R. Sangrey, (unknown), Heather L. Plasterer, Ghazaleh Sadri‐Vakili, Joel Gottesfeld, Leslie M. Thompson, James R. Rusche, Joan Marsh, Elizabeth A. Thomas	137
8	RGFP109, a histone deacetylase inhibitor attenuates l-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: A proof-of-concept study 2012 ·Parkinsonism & Related Disorders ·Tom H. Johnston, Philippe Huot, (unknown), Susan H. Fox, Steven W. Jones, James R. Rusche, Jonathan M. Brotchie	21
9	Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich's Ataxia Patients and in a Mouse Model 2010 ·PLoS ONE ·Myriam Rai, Elisabetta Soragni, C. James Chou, Glenn Barnes, Steve Jones, James R. Rusche, Joel Gottesfeld, Massimo Pandolfo	114
10	Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice 2010 ·Amyotrophic Lateral Sclerosis ·Daniel J. Amante, Jin-Ho Kim, Samantha Carreiro, (unknown), Steven W. Jones, Ting Li, Jennifer P. Moody, Christina K. Edgerly, (unknown), Kerry Cormier, Karen Smith, Robert J. Ferrante, James R. Rusche	16
11	Chemical Probes Identify a Role for Histone Deacetylase 3 in Friedreich's Ataxia Gene Silencing 2009 ·Chemistry & Biology ·Chunping Xu, Elisabetta Soragni, C. James Chou, David Herman, Heather L. Plasterer, James R. Rusche, Joel Gottesfeld	102
12	Partial Reversal of Phencyclidine-Induced Impairment of Prepulse Inhibition by Secretin 2005 ·Biological Psychiatry ·Karyn M. Myers, Martin Goulet, James R. Rusche, Richard Boismenu, Michael J. Davis	7
13	Inhibition of fear potentiated startle in rats following peripheral administration of secretin 2004 ·Psychopharmacology ·Karyn M. Myers, Martin Goulet, James R. Rusche, Richard Boismenu, Michael Davis	18
14	Differential Transport of a Secretin Analog across the Blood-Brain and Blood-Cerebrospinal Fluid Barriers of the Mouse 2002 ·Journal of Pharmacology and Experimental Therapeutics ·William A. Banks, Martin Goulet, James R. Rusche, Michael L. Niehoff, Richard Boismenu	58
15	CTLA4Ig-Induced Linked Regulation of Allogeneic T Cell Responses 2001 ·The Journal of Immunology ·Richard S. Lee, James R. Rusche, Michaella E. Maloney, David H. Sachs, Mohamed H. Sayegh, Joren C. Madsen	25
16	The Amino Terminal Domain of HIV-1 Rev is Required for Discrimination of the RRE from Nonspecific RNA 1995 ·Journal of Molecular Biology ·Thomas J. Daly, (unknown), James R. Rusche, Manfred Auer	28
17	Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate 1991 ·Nucleic Acids Research ·Kathleen Sue Cook, Gregory J. Fisk, Joachim Hauber, Nassim Usman, Thomas J. Daly, James R. Rusche	126
18	C-Terminal Fragments of gpl20 and Synthetic Peptides from Five HTLV-III Strains: Prevalence of Antibodies to the HTLV-III-MN Isolate in Infected Individuals 1990 ·AIDS Research and Human Retroviruses ·Yair Devash, Thomas J. Matthews, J. E. Drummond, Kashi Javaherian, David J. Waters, Larry O. Arthur, William A. Blattner, James R. Rusche	47
19	Circular dichroism studies of the HIV-1 Rev protein and its specific RNA binding site 1990 ·Biochemistry ·Thomas J. Daly, James R. Rusche, Theodore E. Maione, Alan D. Frankel	52
20	The Human Immunodeficiency Virus Type 2 (HIV-2) Contains a Novel Gene Encoding a 16 kD Protein Associated with Mature Virions 1988 ·AIDS Research and Human Retroviruses ·GENOVEFFA FRANCHINI, James R. Rusche, (unknown), Flossie Wong‐Staal	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact